Overview

Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting

Status:
Completed
Trial end date:
2021-02-08
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.
Phase:
Phase 4
Details
Lead Sponsor:
St. Francis Hospital, New York
Treatments:
Azithromycin
Hydroxychloroquine
Zinc Sulfate